Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > 2008 Nanobio Symposium Preview: Donald Ingber

Donald Ingber, speaker at the 2008 NanoBio Symposium at Johns Hopkins University.

Credit: Harvard University
Donald Ingber, speaker at the 2008 NanoBio Symposium at Johns Hopkins University.
Credit: Harvard University

Abstract:
It was the simple elegance of a Kenneth Snelson sculpture that inspired Harvard Medical School Professor Donald Ingber to adopt a more mechanical view of the growth and development of cells and tissue. Ingber will share some of his insights at the NanoBio Symposium on May 2, 2008, hosted by Johns Hopkins University's Institute for NanoBioTechnology.

2008 Nanobio Symposium Preview: Donald Ingber

Baltimore, MD | Posted on December 11th, 2007

Ingber is the Judah Folkman Professor of Vascular Biology in the Department of Pathology at Harvard Medical School, and Departments of Pathology and Surgery at Children's Hospital Boston. He also serves as acting co-director of Harvard's Institute for Biologically Inspired Engineering and Director at Children's Hospital of Harvard's Center for Integration in Medicine and Innovative Technology.
At the symposium Ingber plans to discuss "bio-inspired nanotechnology."

"Nanotechnologists dream of building things that are as multifunctional, capable and flexible as living materials," Ingber says. "I will share what we have learned about how chemical and physical signals, as well as soluble stimuli, regulate cell behavior so that nanotechnologists can leverage this information to build materials that mimic living materials."

The spark that fired Ingber's imagination to investigate cells in novel ways occurred decades ago when, as an undergraduate at Yale, he took a course in sculpture and became intrigued by the forces at work in Snelson's tensegrity models. (The term "tensegrity" was coined from "tension" and "integrity" by architect and designer R. Buckminster Fuller, the namesake of the 60-carbon atom "fullerenes" or "bucky balls.")

Ingber has devoted his career to studying how living cells assemble themselves at the nanometer scale using tensegrity architecture by distributing minute forces over the extracellular matrix (ECM) and intracellular cytoskeleton. ECM, also known as the "basement membrane" in the epithelial lining tissues of our bodies, provides structure and support to cells, as well as aids in cell adhesion, anchoring, and cell-cell communication. A break in the ECM tells pathologists that the cells growing there may be cancerous; 90 percent of the time this is true.

"Pathologists view the extracellular matrix as a host barrier through which a malignant tumor must gain the ability to invade," Ingber says. "I view it as something that regulates cell growth and pattern formation, and when it goes awry, it can lead to cancer development."

To this end, Ingber investigates how cells go about sensing their surroundings and how the ECM contributes to tumor formation. He has authored more than 250 papers of this subject, including seminal publications on how cell surface receptors—integrins—mediate intracellular signals with the ECM and how cytoskeletal networks regulate tissue development.

Read more

* To view some of Ingber's interactive models demonstrating tensegrity in cells, click here.
* To read more about the Ingber Lab, click here.

Symposium

Other confirmed speakers for the 2008 Johns Hopkins University Nano-Bio Symposium include:

* Andrew D. Maynard, Ph.D.
Chief Science Advisor, Project on Emerging Nanotechnologies
Woodrow Wilson International Center for Scholars
* Paras N. Prasad, Ph.D.
Distinguished Professor and Samuel P. Capen Chair of Chemistry
Director, Institute for Lasers, Photonics, and Biophotonics
University of Buffalo, The State University of New York
* Jeffery A. Schloss, Ph.D.
Co-chair, Trans-NIH NANO Task Force
Program Director, Technology Development Coordination
National Human Genome Research Institute, National Institutes of Health
* Jennifer L. West, Ph.D.
Isabel C. Cameron Professor of Bioengineering
Rice University

Participant registration and guidelines for poster submission will be available soon.

Sponsorships opportunities are available now.

####

About Institute for NanoBioTechnology
The Institute for NanoBioTechnology at Johns Hopkins University will revolutionize health care by bringing together internationally renowned expertise in medicine, engineering, the sciences, and public health to create new knowledge and groundbreaking technologies.

INBT programs in research, education, outreach, and technology transfer are designed to foster the next wave of nanobiotechnology innovation.

Approximately 150 faculty are affiliated with INBT and are also members of the following Johns Hopkins institutions: Krieger School of Arts and Sciences, Whiting School of Engineering, School of Medicine, Bloomberg School of Public Health, and Applied Physics Laboratory.

For more information, please click here

Contacts:
Mary Spiro
INBT’s media relations coordinator

410-516-4802.

Copyright © Institute for NanoBioTechnology

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

A nano-roundabout for light December 10th, 2016

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

Events/Classes

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

In IEDM 2016 Keynote, Leti CEO Says ‘Hyperconnectivity’, Human-focused Research and the IOT Promise Profound, Positive Changes December 7th, 2016

IEDM: Leti CEO Marie Semeria to Give Opening-day Keynote on Impact of ‘Hyperconnectivity’ and IoT: Speech to Portray Key Role Nonprofit Research and Technology Organizations Play in Making Technology More Efficient and Ensuring Safety and Security November 29th, 2016

Leti and Grenoble Partners Demonstrate World’s 1st Qubit Device Fabricated in CMOS Process: Paper by Leti, Inac and University of Grenoble Alpes Published in Nature Communications November 28th, 2016

Nanobiotechnology

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project